CHEMOTHERAPY
Online ISSN : 1884-5894
Print ISSN : 0009-3165
ISSN-L : 0009-3165
A LIPID EMULSION FORMULATION OF AMPIIOTERICIN B FOR THE TREATMENT OF MURINE CANDIDIASIS AND CRYPTOCOCCOSIS
TAKASHIGE MIYAZAKISIGERU KOHNOAKIRA YASUOKASHIGEFUMI MAESAKIHIROSHI YAMADAKAZUO SASAYAMAYASUMASA DOHTSUKEIZO YAMAGUCHIMASAKI HIROTAKOHEI HARAKIYOSHI IWAMOTONAOKAZU MURAHASHITadao WATANABE
Author information
JOURNAL FREE ACCESS

1990 Volume 38 Issue 6 Pages 548-551

Details
Abstract

Amphotericin B was incorporated into lipid emulsion using the method of KIRSH R et al. Shortly 20mg of sodium deoxycholate were dissolved in 1.0 ml of dimethylacetamide. This solution was used to solubilize the amphotericin B at various concentrations, and then Intralipos 20%® was added.
The LD50 of amphotericin B lipoid emulsion was more than 5.0 mg/kg in normal BALB/C mice, compared with 1.2 mg/kg for conventional amphotericin B (Fungizoneu®).
In a study of experimental murine disseminated candidiasis, the survival rate of mice given conventional amphotericin B at a dose of 8.0 mg/kg (the maximal tolerated dose without acute lethality) was 20%, whereas the animals treated with amphotericin B in lipid emulsion all were alive 42 days after inoculation (p<0.01).
In the case of experimental murine cryptococcosis, amphotericin B in emulsion also produced higher survival rates than commercial amphotericin B.

Content from these authors
© Japanese Society of Chemotherapy
Previous article Next article
feedback
Top